Matches in Nanopublications for { ?s ?p "[The treatment of patients with aggressive lymphomas has improved significantly in recent years, primarily due to the introduction of targeted therapy with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP308695.RAk0XV3fHf_5ihiDJu9a225yWUmIiYEQK_Ljn0kHGMeFg130_assertion description "[The treatment of patients with aggressive lymphomas has improved significantly in recent years, primarily due to the introduction of targeted therapy with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308695.RAk0XV3fHf_5ihiDJu9a225yWUmIiYEQK_Ljn0kHGMeFg130_provenance.
- NP554878.RAYti7YKS-30jRdiGx7tlm7xL2rHJ4rT_hTkGPMFIpABQ130_assertion description "[The treatment of patients with aggressive lymphomas has improved significantly in recent years, primarily due to the introduction of targeted therapy with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554878.RAYti7YKS-30jRdiGx7tlm7xL2rHJ4rT_hTkGPMFIpABQ130_provenance.
- NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_assertion description "[The treatment of patients with aggressive lymphomas has improved significantly in recent years, primarily due to the introduction of targeted therapy with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554877.RApfTzEp-5UkTR3HCijiKQ8UfN-9E0hNy48sQyGixvV08130_provenance.